Premium
LOPERAMIDE, AN OPIATE ANALOGUE, INHIBITS PLASMA ACTH LEVELS IN PATIENTS WITH ADDISON'S DISEASE
Author(s) -
AMBROSI B.,
BOCHICCHIO D.,
FAGLIA G.
Publication year - 1986
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1986.tb03276.x
Subject(s) - loperamide , endocrinology , medicine , opiate , (+) naloxone , chemistry , receptor , opioid , diarrhea
SUMMARY The effects of loperamide, an opiate analogue of the piperidine class on pituitary hormone secretion were evaluated in eight patients with Addison's disease. In all patients loperamide administration (16 mg orally) induced a marked fall in plasma ACTH levels ( P <0.01), without affecting GH, PRL and LH levels. Plasma ACTH concentration fell significantly from 854±167 pg/ml (mean±SEM) to 460±123 pg/ml at 60 min ( P ±0.01). The inhibition persisted throughout the whole test period, the nadir being reached at 300 min. Low dose naloxone infusion 180 min after loperamide administration caused plasma ACTH to rise from 181±61 pg/ml to 539±99 pg/ml ( P ±0.01). The present data suggest that the opiate analogue loperamide is a potent inhibitor of ACTH secretion in patients with Addison's disease, which may be acting on μ receptors, since its effect is blocked by low doses of naloxone.